Patents by Inventor Takao Shimatani

Takao Shimatani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11191729
    Abstract: The use of a granular material which is for orally fast disintegrating tablets and comprises starch and tannic acid allows provision of tablets that can be produced by a simple process with general-purpose production equipment, disintegrate fast and absorbs water in the mouth, and have a proper level of shape retainability for practical use. The present invention also provides a method for producing an orally fast disintegrating tablet, the method comprising compression molding of a granular material for orally fast disintegrating tablets comprising starch and tannic acid, or a mixture of the granular material for orally fast disintegrating tablets and other ingredients (an additive, an active ingredient, and/or the like).
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: December 7, 2021
    Assignee: Teika Pharmaceutical Co., Ltd.
    Inventors: Takao Shimatani, Yutaka Hasegawa, Hiroko Ito, Takahiro Kawagishi, Naohisa Wada, Atsushi Yamada
  • Publication number: 20200297641
    Abstract: The use of a granular material which is for orally fast disintegrating tablets and comprises starch and tannic acid allows provision of tablets that can be produced by a simple process with general-purpose production equipment, disintegrate fast and absorbs water in the mouth, and have a proper level of shape retainability for practical use. The present invention also provides a method for producing an orally fast disintegrating tablet, the method comprising compression molding of a granular material for orally fast disintegrating tablets comprising starch and tannic acid, or a mixture of the granular material for orally fast disintegrating tablets and other ingredients (an additive, an active ingredient, and/or the like).
    Type: Application
    Filed: February 16, 2017
    Publication date: September 24, 2020
    Applicant: Teika Pharmaceutical Co., Ltd.
    Inventors: Takao SHIMATANI, Yutaka HASEGAWA, Hiroko ITO, Takahiro KAWAGISHI, Naohisa WADA, Atsushi YAMADA
  • Patent number: 9463165
    Abstract: The use of a granular material which is for orally fast disintegrating tablets and comprises at least one kind of water soluble polymer and tannic acid allows production of tablets that can be produced by a simple process with simple production equipment, disintegrate fast in the mouth, and have a proper level of moldability for practical use. The at least one kind of water soluble polymer is preferably selected from the group consisting of povidone, hydroxypropyl cellulose, pullulan, a polyvinyl alcohol-polyethylene glycol graft copolymer and copolyvidone.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: October 11, 2016
    Assignee: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takao Shimatani, Takahiro Kawagishi
  • Publication number: 20150238426
    Abstract: The use of a granular material which is for orally fast disintegrating tablets and comprises at least one kind of water soluble polymer and tannic acid allows production of tablets that can be produced by a simple process with simple production equipment, disintegrate fast in the mouth, and have a proper level of moldability for practical use. The at least one kind of water soluble polymer is preferably selected from, the group consisting of povidone, hydroxypropyl cellulose, pallulan, a polyvinyl alcohol-polyethylene glycol graft copolymer and copolyvidone.
    Type: Application
    Filed: September 4, 2013
    Publication date: August 27, 2015
    Inventors: Takao Shimatani, Takahiro Kawagishi
  • Publication number: 20130281529
    Abstract: It is intended to provide an eye drop preparation capable of preventing not only degradation of latanoprost in water but also adsorption of latanoprost onto a plastic container so that a decrease in latanoprost content thereof is satisfactorily prevented. The eye drop preparation contains an ophthalmic solution composition containing components (A) and (B) and packed in a plastic container: (A) latanoprost; and (B) a nonionic surfactant.
    Type: Application
    Filed: June 20, 2013
    Publication date: October 24, 2013
    Inventors: Takahito Kimura, Joshu Watanabe, Minoru Kobayashi, Makoto Seki, Takao Shimatani, Chiharu Takagi
  • Publication number: 20100120908
    Abstract: Disclosed is an eye drop preparation comprising latanoprost, which is characterized in that the degradation of latanoprost in water can be prevented, the adsorption of latanoprost onto a plastic container can be prevented, and therefore the decrease in the latanoprost content can be prevented satisfactorily. The eye drop preparation comprises an eye drop composition comprising the following components (A)-(B) and packed in a plastic container: (A) latanoprost; and (B) a nonionic surfactant.
    Type: Application
    Filed: February 7, 2008
    Publication date: May 13, 2010
    Applicant: TEIKA PHARMACEUTICAL CO., LTD
    Inventors: Takahito Kimura, Joshu Watanabe, Minoru Kobayashi, Makoto Seki, Takao Shimatani, Chiharu Takagi